Recce Pharma heading closer to full efficacy data for flagship R327
Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial has been dosed.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online